Glipizide Tablet, Extended Release
Product Images NDC 70518-4128

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-4128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Glipizide 10 mg extended-release oral tablets packaging label showing quantity of 30 tablets. Label includes the brand name, dosage strength, and manufacturer details with storage directions. It indicates the product is repackaged by Remedy Repack Inc. and includes an NDC number 70518-4128-00 and source manufacturer Aurobindo, India.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure diagram of Glipizide, showing its molecular arrangement with distinct rings, bonds, and functional groups characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.